Fine needle aspiration.

Cancer Invest

Departament of Pathology, Mount Sinai Medical Center, New York, New York 10029, USA.

Published: December 2004

Fine needle aspiration (FNA) has been widely used as a diagnostic tool for the past half century. Differing from large bore cutting needle biopsy, FNA utilizes 22- to 27-gauge needles. The cell samples aspirated from a lesion are characteristically smeared on glass slides for immediate microscopic evaluation. An adequacy report and a preliminary diagnostic impression are rendered in approximately 10 to 15 minutes. A final report is generally rendered within 24 hours. The method has been used as one of the most cost-effective, complication-free, and rapid techniques for preoperative investigation of tumors and tumor-like conditions. Its usefulness in the diagnosis and management of oncology patients is emphasized in this article.

Download full-text PDF

Source
http://dx.doi.org/10.1081/cnv-200027160DOI Listing

Publication Analysis

Top Keywords

fine needle
8
needle aspiration
8
aspiration fine
4
aspiration fna
4
fna diagnostic
4
diagnostic tool
4
tool half
4
half century
4
century differing
4
differing large
4

Similar Publications

Background: Thyroid nodules classified cytologically as low-risk indeterminate lesions (TIR3A) on fine-needle aspiration biopsy (FNAB) present a clinical challenge due to their uncertain malignancy risk. This single-center study aimed to evaluate the natural history of TIR3A nodules.

Materials And Methods: FNABs performed between July 2017 and December 2019 were retrospectively retrieved and patients with TIR3A nodules were evaluated at baseline and throughout a follow-up based on ultrasound (US) parameters and clinical data.

View Article and Find Full Text PDF

Objective: An accurate fine-needle aspiration (FNA) diagnosis of adrenal lesions may be challenging. This study was to investigate roles of imaging guidance, rapid on-site evaluation (ROSE) and additional tissue sampling in FNA diagnosis of adrenal lesions.

Methods: Adrenal FNA cases were retrieved from pathology archive.

View Article and Find Full Text PDF

Primary cutaneous anaplastic large cell lymphoma (ALCL) is a very uncommon type of CD30-positive T-cell lymphoma, and it very rarely affects the forehead. We report the case of a 68-year-old male presenting with an ulcerative lesion on the right forehead, initially suspected as a benign condition. Fine needle aspiration suggested a lymphoproliferative disorder, with biopsy and immunohistochemistry confirming primary cutaneous ALCL (CD30-positive, anaplastic lymphoma kinase [ALK]-negative).

View Article and Find Full Text PDF

This study aimed to evaluate the impact of different manipulation methods and storage environments on the microstructural, chemical, and mechanical properties of calcium-enriched mixture (CEM) cement. Four sample groups were examined, including nondried (ND-I) and dried (D-I) groups placed directly in an incubator, dried samples stored in phosphate-buffered saline (PBS) (D-P), and dried samples stored in distilled water (D-W). Various analyses, including Vickers microhardness, compressive strength, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and scanning electron microscopy (SEM) with energy-dispersive X-ray spectroscopy (EDS) were conducted after incubating the samples for 7 days.

View Article and Find Full Text PDF

Introduction: Limited information exists on next-generation sequencing (NGS) success for lung tumors of 30 mm or less. We aimed to compare NGS success rates across biopsy techniques for these tumors, assess DNA sequencing quality, and verify reliability against surgical resection results.

Methods: We used data from the Initiative for Early Lung Cancer Research on Treatment study, including patients with lung tumors measuring 30 mm or less who had surgery and NGS on biopsies since 2016.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!